Recurrent Intestinal Perforation After Cessation of Immunosuppression in Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipient
- 22 March 2021
- journal article
- case report
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 52 (3) , 1165-1168
Abstract
Posttransplant lymphoproliferative disease (PTLD) is the most common malignant complication after solid organ transplantation. Gastrointestinal involvement as the presentation in early PTLD can occur in 25–30% of pediatric liver transplant recipients and can be the only system involved in 20%. Recurrent gastrointestinal perforation due to resolution of PTLD is an extremely rare complication. We report a 13-month-old male child diagnosed with PTLD, treatment of which lead to recurrent intestinal perforations. The child presented with gastrointestinal bleed 5 months after living donor liver transplantation for biliary atresia. Evaluation was suggestive of PTLD and biopsy confirmed diffuse large B-cell lymphoma. Positron emission tomography scan showed diffuse involvement of small intestine and ileum. Tacrolimus was withdrawn abruptly following diagnosis of PTLD as there was associated renal impairment. Child developed six episodes of small intestinal perforations over 3 weeks which required multiple laparotomies with closure of perforation and/or small bowel resection. Complete remission was achieved six months after diagnosis with cessation of immunosuppression alone and child is alive at 48 months follow-up without any recurrence. To avoid bowel perforation and complications related to tumor necrosis, immunosuppression reduction in PTLD should be gradual while carefully monitoring Epstein–Barr virus levels, tumor response, graft function, and general health status of the patient.Keywords
This publication has 9 references indexed in Scilit:
- Septic Complications and Graft Outcome after Post-Transplant Lymphoproliferative Disorder in Paediatric Solid Organ Transplant Patients in the Rituximab EraTransplantation, 2018
- Poorer Long-Term Survival Associated with Monomorphic Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation in ChildrenTransplantation, 2018
- Risk factors and clinical outcomes of pediatric liver transplant recipients with post‐transplant lymphoproliferative disease in a multi‐ethnic Asian cohortTransplant Infectious Disease, 2017
- Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ TransplantationJournal of Immunology Research, 2013
- Lymphoproliferative disorders in pediatric liver allograft recipientsHematology/Oncology and Stem Cell Therapy, 2012
- Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantationCancer Chemotherapy and Pharmacology, 2009
- Post‐transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: Report of five pediatric casesPediatric Transplantation, 2006
- REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1Transplantation, 2001
- The Involvement of the Gastrointestinal Tract in Posttransplant Lymphoproliferative Disease in Pediatric Liver TransplantationJournal of Pediatric Gastroenterology and Nutrition, 1999